📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A randomised controlled pilot trial of oral 11ß-HSD1 inhibitor AZD4017 for wound healing in adults with type 2 diabetes mellitus (2021)

First Author: Ajjan R

Attributed to: MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.03.23.21254200

Publication URI: http://dx.doi.org/10.1101/2021.03.23.21254200

Type: Preprint